[Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases].
D000818:Animals; D001932:Brain Neoplasms / Q000628:therapy*; D001973:Bromodeoxyuridine / Q000378:metabolism / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000628:therapy; D006224:Cricetinae; D004273:DNA, Neoplasm / Q000378:metabolism; D005260:Female; D005467:Floxuridine / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007065:Idoxuridine / Q000378:metabolism / Q000627:therapeutic use*; D008325:Mammary Neoplasms, Experimental / Q000628:therapy; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000628:therapy; D014176:Protein Biosynthesis / Q000187:drug effects; D011838:Radiation-Sensitizing Agents / Q000378:metabolism / Q000627:therapeutic use*; D013936:Thymidine / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects
D004273:DNA, Neoplasm; D011838:Radiation-Sensitizing Agents; D005467:Floxuridine; D001973:Bromodeoxyuridine; D007065:Idoxuridine; D013936:Thymidine
Radiosensibilizatsiia opukholeĭ golovnogo mozga galoidirovannymi analogami pirimidinovykh osnovaniĭ.